CHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.111000E-01
Normal-vs-Stage2
5.131800E-01
Normal-vs-Stage3
3.029000E-01
Normal-vs-Stage4
5.270600E-01
Stage1-vs-Stage2
6.092800E-01
Stage1-vs-Stage3
2.358400E-02
Stage1-vs-Stage4
9.701000E-01
Stage2-vs-Stage3
1.653960E-01
Stage2-vs-Stage4
6.554600E-01
Stage3-vs-Stage4
2.750500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.916600E-01
Normal-vs-AfricanAmerican
7.932400E-01
Normal-vs-Asian
4.065200E-01
Caucasian-vs-AfricanAmerican
4.076000E-01
Caucasian-vs-Asian
3.557400E-01
AfricanAmerican-vs-Asian
1.588790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.880800E-01
Normal-vs-Female
5.106200E-01
Male-vs-Female
6.955000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.157600E-01
Normal-vs-Age(41-60Yrs)
3.478200E-01
Normal-vs-Age(61-80Yrs)
4.390400E-01
Normal-vs-Age(81-100Yrs)
4.197400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.531900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.889900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.559200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.557870E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.886200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.133400E-01
Normal-vs-Daily Drinker
4.599800E-01
Normal-vs-Weekly Drinker
2.130200E-01
Normal-vs-Occasional Drinker
4.927200E-01
Normal-vs-Social Drinker
5.158800E-01
Non Drinker-vs-Daily Drinker
5.816600E-01
Non Drinker-vs-Weekly Drinker
5.513400E-01
Non Drinker-vs-Occasional Drinker
3.623000E-01
Non Drinker-vs-Social Drinker
2.970000E-01
Daily Drinker-vs-Weekly Drinker
9.048000E-01
Daily Drinker-vs-Occasional Drinker
7.555200E-01
Daily Drinker-vs-Social Drinker
6.450200E-01
Weekly Drinker-vs-Occasional Drinker
8.892200E-01
Weekly Drinker-vs-Social Drinker
7.852800E-01
Occasional Drinker-vs-Social Drinker
8.605400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.728990E-01
Normal-vs-Grade 2
9.538400E-03
Normal-vs-Grade 3
2.002000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.035600E-01
Grade 1-vs-Grade 3
5.388600E-01
Grade 1-vs-Grade 4
1.728990E-01
Grade 2-vs-Grade 3
9.795200E-01
Grade 2-vs-Grade 4
9.538400E-03
Grade 3-vs-Grade 4
2.002000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.600800E-01
Normal-vs-NonDiabetic
4.602800E-01
Diabetic-vs-NonDiabetic
9.659600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.785980E-01
Normal-vs-NoPancreatitis
4.570200E-01
Pancreatitis-vs-NoPancreatitis
9.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.695800E-01
Normal-vs-N1
5.084800E-01
N0-vs-N1
5.218600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.649600E-01
Normal-vs-TP53-NonMutant
1.644570E-01
TP53-Mutant-vs-TP53-NonMutant
3.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
